These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10911749)

  • 1. [Early screening of fetal aneuploidies (c-beta P/us TEST). Report of 600 observations].
    Pescia G; Ditesheim PJ; Faway C; Nguyen-The H; Schmid D; Brioschi PA
    Rev Med Suisse Romande; 2000 May; 120(5):435-41. PubMed ID: 10911749
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of nucleated red blood cells in maternal circulation: a second step in screening for fetal aneuploidies and pregnancy complications.
    Mavrou A; Kouvidi E; Antsaklis A; Souka A; Kitsiou Tzeli S; Kolialexi A
    Prenat Diagn; 2007 Feb; 27(2):150-3. PubMed ID: 17186566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive prenatal diagnosis by single molecule counting technologies.
    Chiu RW; Cantor CR; Lo YM
    Trends Genet; 2009 Jul; 25(7):324-31. PubMed ID: 19540612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal testing for aneuploidy in New Zealand: time for action.
    Stone P
    N Z Med J; 2005 Jun; 118(1217):U1545. PubMed ID: 15980916
    [No Abstract]   [Full Text] [Related]  

  • 5. Advanced first trimester screening (AFS): an improved test strategy for the individual risk assessment of fetal aneuploidies and malformations.
    Schmidt P; Rom J; Maul H; Vaske B; Hillemanns P; Scharf A
    Arch Gynecol Obstet; 2007 Aug; 276(2):159-66. PubMed ID: 17342500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The introduction of QF-PCR in prenatal diagnosis of fetal aneuploidies: time for reconsideration.
    Nicolini U; Lalatta F; Natacci F; Curcio C; Bui TH
    Hum Reprod Update; 2004; 10(6):541-8. PubMed ID: 15514017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular biology usefulness for rapid diagnosis of Down's syndrome and common aneuploidies].
    Fauret AL; Bilan F; Patri S; Couet D; Marechaud M; Pierre F; Gilbert-Dussardier B; Kitzis A
    Gynecol Obstet Fertil; 2009; 37(7-8):611-9. PubMed ID: 19574080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cell-free nucleic acid-based non-invasive prenatal diagnosis of fetal aneuploidies].
    Lázár L; Nagy GR; Rigó J; Nagy B
    Orv Hetil; 2012 Oct; 153(43):1687-91. PubMed ID: 23089167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New frontiers in noninvasive, prenatal screening and diagnosis: fetal DNA circulating in maternal blood].
    Montagnana M; Lippi G; Guidi GC
    Minerva Ginecol; 2007 Jun; 59(3):331-41. PubMed ID: 17576408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive prenatal diagnosis in 2020.
    Lo YM
    Prenat Diagn; 2010 Jul; 30(7):702-3. PubMed ID: 20572103
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis.
    Wright CF; Burton H
    Hum Reprod Update; 2009; 15(1):139-51. PubMed ID: 18945714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cell-free fetal DNA detection in maternal plasma using real-time PCR and cycling probe technology for prenatal screening beta-thalassaemia major].
    Chen X; Ren JH; Guo H; Lin LH; Yao QX
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1210-3. PubMed ID: 18676265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood.
    Sekizawa A; Purwosunu Y; Matsuoka R; Koide K; Okazaki S; Farina A; Saito H; Okai T
    J Obstet Gynaecol Res; 2007 Dec; 33(6):747-64. PubMed ID: 18001438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Three-dimensional scatter plot analysis to estimate the risk of foetal aneuloidy].
    Schmidt P; Hörmansdörfer C; Oehler K; Härtel H; Hillemanns P; Scharf A
    Z Geburtshilfe Neonatol; 2008 Aug; 212(4):127-35. PubMed ID: 18729035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of circulating fetal nucleic acids: a review of methods and applications.
    Hung EC; Chiu RW; Lo YM
    J Clin Pathol; 2009 Apr; 62(4):308-13. PubMed ID: 19329710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized criteria for using fluorescence in situ hybridization in the prenatal diagnosis of common aneuploidies.
    Leclercq S; Lebbar A; Grange G; Tsatsaris V; Le Tessier D; Dupont JM
    Prenat Diagn; 2008 Apr; 28(4):313-8. PubMed ID: 18306148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
    Bauer M; Hutterer G; Eder M; Majer S; Leshane E; Johnson KL; Peter I; Bianchi DW; Pertl B
    Prenat Diagn; 2006 Sep; 26(9):831-6. PubMed ID: 16832830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introductory editorial: prenatal diagnosis and fetal surgery.
    Lakhoo K
    Early Hum Dev; 2012 Jan; 88(1):1. PubMed ID: 22137248
    [No Abstract]   [Full Text] [Related]  

  • 20. Aneuploidy screening: what test should I use?
    Berkowitz RL; Cuckle HS; Wapner R; D'Alton ME
    Obstet Gynecol; 2006 Mar; 107(3):715-8. PubMed ID: 16507946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.